Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type

Type

Guidance programme

Advice programme

Showing 651 to 700 of 2518

TitleReference numberPublishedLast updated
Tucatinib with trastuzumab and capecitabine for treating HER2-positive advanced breast cancer after 2 or more anti-HER2 therapiesTA786
Elosulfase alfa for treating mucopolysaccharidosis type 4AHST19
Intramedullary distraction for upper limb lengtheningIPG722
Medicines associated with dependence or withdrawal symptoms: safe prescribing and withdrawal management for adultsNG215
Niraparib for maintenance treatment of relapsed, platinum-sensitive ovarian, fallopian tube and peritoneal cancerTA784
Nivolumab with cabozantinib for untreated advanced renal cell carcinoma (terminated appraisal)TA785
Stroke and transient ischaemic attack in over 16s: diagnosis and initial managementNG128
Daratumumab monotherapy for treating relapsed and refractory multiple myelomaTA783
Diabetes in children and young peopleQS125
UroShield for preventing catheter-associated urinary tract infectionsMTG69
Freelite assays for diagnosing multiple myeloma and related conditions (terminated assessment)DG47
Sotorasib for previously treated KRAS G12C mutation-positive advanced non-small-cell lung cancerTA781
Tagraxofusp for treating blastic plasmacytoid dendritic cell neoplasm (terminated appraisal)TA782
Joint replacement (primary): hip, knee and shoulderQS206
Liposuction for chronic lipoedemaIPG721
icobrain ms for active relapsing–remitting multiple sclerosisMIB291
Atidarsagene autotemcel for treating metachromatic leukodystrophyHST18
Nivolumab with ipilimumab for untreated advanced renal cell carcinomaTA780
Neonatal parenteral nutritionQS205
Fetal alcohol spectrum disorderQS204
Integrated health and social care for people experiencing homelessnessNG214
Dostarlimab for previously treated advanced or recurrent endometrial cancer with high microsatellite instability or mismatch repair deficiencyTA779
SecurePort IV tissue adhesive for use with percutaneous cathetersMIB288
Otitis media (acute): antimicrobial prescribingNG91
Percutaneous insertion of a cystic duct stent after cholecystostomy for acute calculous cholecystitisIPG720
Empagliflozin for treating chronic heart failure with reduced ejection fractionTA773
Lenalidomide for relapsed or refractory mantle cell lymphoma (terminated appraisal)TA774
Pitolisant hydrochloride for treating excessive daytime sleepiness caused by obstructive sleep apnoeaTA776
Solriamfetol for treating excessive daytime sleepiness caused by obstructive sleep apnoeaTA777
Pegcetacoplan for treating paroxysmal nocturnal haemoglobinuriaTA778
Prontosan for treating acute and chronic woundsMTG67
3C Patch for treating diabetic foot ulcersMTG66
Endoscopic balloon dilation for subglottic or tracheal stenosisIPG719
Endoscopic full thickness removal of gastrointestinal stromal tumours of the stomachIPG717
Intramedullary distraction for lower limb lengtheningIPG718
Mental wellbeing at workNG212
Lumella point-of-care test for assessing pre-eclampsia riskMIB287
PredictSURE IBD and IBDX to guide treatment of Crohn's diseaseDG45
EarlyCDT Lung for assessing risk of lung cancer in solid lung nodulesDG46
Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma after stem cell transplant or at least 2 previous therapiesTA772
Odevixibat for treating progressive familial intrahepatic cholestasisHST17
The Insides System for managing intestinal failureMIB286
Pembrolizumab with carboplatin and paclitaxel for untreated metastatic squamous non-small-cell lung cancerTA770
Daratumumab with bortezomib, melphalan and prednisone for untreated multiple myeloma (terminated appraisal)TA771
d-Nav insulin management app for type 2 diabetesMIB285
Stereotactic radiosurgery for trigeminal neuralgiaIPG715
Microwave ablation for primary or metastatic cancer in the lungIPG716
Daratumumab in combination for untreated multiple myeloma when a stem cell transplant is suitableTA763
Fremanezumab for preventing migraineTA764
Venetoclax with azacitidine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitableTA765

Results per page

  1. 10
  2. 25
  3. 50
  4. All